Acceptability, Feasibility and Safety of a Yoga Program for Chronic Pain in Sickle Cell Disease
TerminatedNot applicableNCT03694548
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Chronic Pain is associated with morbidity and poor quality of life in patients with Sickle Cell Disease (SCD). Complementary therapies, such as yoga are beneficial in patients with non-SCD chronic pain conditions. Yoga was shown to be acceptable, feasible and helpful in one study in acute SCD pain. The purpose of the study is to assess the acceptability, feasibility, and safety of yoga for chronic pain in SCD.
Study details
- Official title
- Acceptability, Feasibility and Safety of a Yoga Program for Chronic Pain in Sickle Cell Disease
- Conditions
- Interventions
- Behavioral: Part A Survey
- Behavioral: Part B Yoga Program
- Sponsor
- Emory University
- Start date
- 2018-11-08
- Primary completion
- 2020-03-09
- Sex
- All
- Age range
- from 12 Years to 21 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * SCD, any genotype * Presence of chronic pain, the presence of chronic pain will be defined based on the frequency characteristic of the Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks (ACTTION)-American Pain Society Pain Taxonomy (AAPT) criteria for chronic SCD pain, as the presence of SCD-related pain on 15 or more days of the month, for the past 6 months * Age 12 -21 at time of enrollment * English speaking Exclusion Criteria: * Daytime or nighttime oxygen requirement for hypoxia * Most recent hemoglobin \< 5 or platelet count \< 20 * Known pregnancy * Severe cognitive issues not allowing for understanding consent/assent and instructions * History of overt stroke with significant residual motor weakness * History of recurrent syncope * Any other comorbidities or health concerns that the treating healthcare provider or investigators feel are a contra-indication for participation in the study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03694548